Table 1.
Patients’ demographics, stone and renal characteristics.
| Variable | Group D (Dusting) | Group F (Fragmentation) | P |
|---|---|---|---|
| N (%): | |||
| Patients | 0.962* | ||
| Male | 28 (55) | 31 (55.4) | |
| Female | 23 (45) | 25 (44.6) | |
| ASA Score | 0.452* | ||
| 1 | 31 (60.8) | 30 (53.6) | |
| 2 | 20 (39.2) | 26 (46.4) | |
| Side | 0.168* | ||
| Right | 17 (33.3) | 26 (46.4) | |
| Left | 34 (66.7) | 30 (53.6) | |
| UTI (positive culture) | 12 (23.5) | 15 (26.8) | 0.699* |
| Recurrent stone disease | 19 (37.3) | 18 (32.1) | 0.579* |
| Stone number | 0.789* | ||
| Single | 26 (51) | 30 (53.6) | |
| Multiple | 25 (49) | 26 (46.4) | |
| Stone site | 0.168* | ||
| Renal pelvis | 11 (21.6) | 12 (29.4) | |
| Calyceal | 25 (49) | 20 (35.7) | |
| Multiple sites | 15 (29.4) | 24 (42.9) | |
| Preoperative stent | 34 (66.7) | 38 (67.9) | 0.896 |
| Mean (SD): | |||
| Age, years | 49.2 (13.2) | 50.5 (13.4) | 0.618# |
| Creatinine, µmol/L | 86.7 (9.1) | 82.3 (18) | 0.212# |
| Stone length, mm | 14.5 (5.5) | 14.4 (6.9) | 0.945# |
*chi-squared test; #t-test.